Prof. K. Bhatia

Clinical Movement Disorders Group

Lab Head: Professor Kailash Bhatia

Clinical trials of:

• rotigotine dopamine agonist patch in Parkinson’s disease (PD)

• synthetic human growth hormone in multiple system atrophy (MSA)

• riluzole in MSA and progressive supranuclear palsy (PSP).

• National PD-SURG trials in PD

• London/Lund/Marburg programme of fetal nigral mesencephalic grafting in PD.

• Development of MSA rating scale and therapeutic trial assessment protocols, and of Quality of Life scales for MSA and PSP.

Clinical research projects on:

• repetitive transcranial magnetic stimulation (rTMS) in movement disorders

• the syndrome of fixed dystonia

• DYT1 gene carriers with and without dystonia

Group members

Prof. Kailash Bhatia MD, DM, FRCP k.bhatia{at}ion.ucl.ac.uk

Dr Caroline Selai MSc, PhD c.selai{at}ion.ucl.ac.uk

Collaborations:

1 Other research departments in the Institute of Neurology

2 MRC Cyclotron Unit (Prof D J Brooks), RPMS, Hammersmith Hospital

3 European MSA Study Group (www.EMSA-SG.org)

4 Wallenberg Neuroscience Centre, Lund University, Sweden

5 European Dystonia Epidemiology Group

The UCL Institute of Neurology promotes teaching and research of the highest quality in neurology and the neurosciences. The Institute of Neurology and the National Hospital for Neurology and Neurosurgery are members of  UCL Partners, Europe's largest academic health science partnership.